Literature DB >> 18192343

Intrathecal gadolinium: its time has come?

W P Dillon.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18192343      PMCID: PMC8119075          DOI: 10.3174/ajnr.A0884

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  11 in total

1.  MRI cisternography with gadolinium-containing contrast medium: its role, advantages and limitations in the investigation of rhinorrhoea.

Authors:  K Aydin; K Guven; S Sencer; J R Jinkins; O Minareci
Journal:  Neuroradiology       Date:  2003-11-13       Impact factor: 2.804

2.  Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study.

Authors:  E Turgut Tali; Nil Ercan; Gaida Krumina; Mohammed Rudwan; Angel Mironov; Qing Yu Zeng; J Randy Jinkins
Journal:  Invest Radiol       Date:  2002-03       Impact factor: 6.016

Review 3.  Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.

Authors:  Rush H Chewning; Kieran J Murphy
Journal:  J Vasc Interv Radiol       Date:  2007-03       Impact factor: 3.464

4.  Gadolinium encephalopathy in a patient with renal failure.

Authors:  Boby Varkey Maramattom; Edward M Manno; Eelco F M Wijdicks; Edward P Lindell
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

5.  Intrathecal gadolinium-enhanced MR myelography and cisternography: a pilot study in human patients.

Authors:  Q Zeng; L Xiong; J R Jinkins; Z Fan; Z Liu
Journal:  AJR Am J Roentgenol       Date:  1999-10       Impact factor: 3.959

6.  Cisternography and ventriculography gadopentate dimeglumine-enhanced MR imaging in pediatric patients: preliminary report.

Authors:  A Muñoz; J Hinojosa; J Esparza
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

7.  Increased signal in the subarachnoid space on fluid-attenuated inversion recovery imaging associated with the clearance dynamics of gadolinium chelate: a potential diagnostic pitfall.

Authors:  J M Morris; G M Miller
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

8.  Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: preliminary report.

Authors:  J R Jinkins; R F Williams; L Xiong
Journal:  Invest Radiol       Date:  1999-02       Impact factor: 6.016

9.  Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts.

Authors:  E Turgut Tali; Nil Ercan; Memduh Kaymaz; Aydin Pasaoglu; J Randy Jinkins
Journal:  Neuroradiology       Date:  2004-09       Impact factor: 2.804

10.  Gadolinium-enhanced MR cisternography to evaluate dural leaks in intracranial hypotension syndrome.

Authors:  S Albayram; F Kilic; H Ozer; S Baghaki; N Kocer; C Islak
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-18       Impact factor: 3.825

View more
  2 in total

1.  MR Myelography for the Detection of CSF-Venous Fistulas.

Authors:  J L Chazen; M S Robbins; S B Strauss; A D Schweitzer; J P Greenfield
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-30       Impact factor: 3.825

2.  Phase-contrast cine MRI versus MR cisternography on the evaluation of the communication between intraventricular arachnoid cysts and neighbouring cerebrospinal fluid spaces.

Authors:  Oktay Algin; Bahattin Hakyemez; Gokhan Gokalp; Ender Korfali; Mufit Parlak
Journal:  Neuroradiology       Date:  2009-01-27       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.